Sea Mild Biotechnology Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was TWD 65.847 million compared to TWD 122.180 million a year ago. Operating loss was TWD 24.716 million compared to TWD 15.887 million a year ago. Net loss was TWD 31.675 million compared to TWD 14.421 million a year ago. Basic loss per share from continuing operations was TWD 1.64 compared to TWD 0.75 a year ago.